Navigation Links
PRA International's Drug Safety Experts to Speak at Safety Congress

RALEIGH, N.C., Sept. 13 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two of its leading drug safety experts will present at the 4th annual World Drug Safety Congress to be held in London 14 -17 September 2010. PRA will also host a conference exhibit.

Dr. Sabine Richter, PRA's Vice President of Safety & Risk Management (SRM) and a conference chair, will make the opening remarks for the Thursday morning session on pre-clinical and clinical safety strategies. Dr. Angelika Schneider, Director of PRA's Drug Safety Centers in Europe, Asia-Pacific and Africa, will discuss the challenges of global compliance in the current regulatory environment in her Thursday afternoon session. She will also review a PRA-developed repository that contains the diverse safety reporting requirements for more than 60 countries.

At booth 11, PRA drug safety managers will be available to discuss PRA's successful experience in SRM engagements for sponsor.

As vice president, Dr. Richter is responsible for all aspects of PRA's SRM services. To ensure consistent high performance and regulatory compliance, Dr. Richter has developed robust procedures and quality control measures. Dr. Schneider has nearly 15 years of experience in clinical research and pharmacovigilance. Over the last six years, she has led several large pharmacovigilance projects both in the pre- and post-marketing settings.

PRA provides safety and risk management services during the entire product life cycle. Our SRM team of more than 110 experts is available to our clients for consultancy as well as routine and specialty pharmacovigilance services. Our drug safety centers are based in Mannheim, Germany; Charlottesville, VA (US); and Sao Paulo, Brazil.

For more information about the World Drug Safety Congress, navigate to and click on "Events."

About PRA International

PRA International conducts clinical trials in more than 85 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 38 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit, email or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kalispell Regional Medical Center to Implement the SurgiCount Safety-Sponge® System
2. Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation
3. Seeking Safety in Supplements
4. Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year
5. FDAs New Safety Controls for LABA-Containing Drugs Will Impact Prescribing of Single-Agent ICS and LABA/ICS Combination Therapies for the Treatment of Asthma
6. FDA CONSUMER HEALTH INFORMATION - FDAs MedWatch Safety Alerts: July 2010
7. OXIS International, Inc. Announces Publication of Positive Results of Ergothioneine Safety Study in the Journal TOXICOLOGY
8. Multi-centre Phase II Trial Reports Safety and Clinical Benefits of Radioactive Microspheres in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy
9. Patient Safety Technologies Reports Second Quarter 2010 Results
10. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
11. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
Post Your Comments:
(Date:11/30/2015)... and SAN DIEGO , Nov. ... Inc. (NASDAQ: ARNA ) today announced that the ... filing the New Drug Application (NDA) for an extended ... formulation will offer patients a chronic weight management treatment ... ) is currently approved as an adjunct to a ...
(Date:11/30/2015)... ST. LOUIS , Nov. 30, 2015  Premera ... today announced an early renewal of the companies, long-standing ... will now extend through at least 2019. ... pharmacy benefit manager capabilities during a competitive review and ... offer the best health plan integration and deliver the ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... ... The successful filing of an Investigational New Drug application (IND) is a ... key industry segment, Regis Technologies has decided to sponsor and participate in an XTalks-hosted ... , Federal law does not allow new drugs to cross state lines until it ...
(Date:11/30/2015)... ... November 30, 2015 , ... SIMmersion’s ability to present dynamic ... schools of the future. To reach an audience of key visionaries and reformers ... in Chicago, organized by the American Medical Association. , AMA President Steven ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... Service, Inc. are pleased to announce their strategic partnership at the Radiological ... Keystrokes Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and ...
(Date:11/30/2015)... ... ... today announced the introduction of three Nightstick® brand LED traffic wands with an average retail ... NSP-1632 ), yellow ( NSP-1634 ) and blue ( NSP-1636 ), the SL-1600 series LED ... in blinking strobe mode using a fresh set of 3 AAA cells (included). , Built ...
(Date:11/29/2015)... ... ... The Cyber Monday deal is a deep 40% or more discount on every item on ... the skin care lover in your circle. Each Christmas, Sublime Beauty offers a special ... serums are staples: Collagen, Retinol and Hyaluronic Serums. , Stocking stuffers like Skin Brushes, natural ...
Breaking Medicine News(10 mins):